Premium
Premium statistics

Industry-specific and extensively researched technical data (partially from exclusive partnerships).

A paid subscription is required for full access.

Annual testosterone drug revenue in the U.S. in 2013 and 2018 (in billion U.S. dollars)

Exclusive Premium Statistic

Annual testosterone drug revenue in the United States 2013 and 2018 This statistic depicts the annual testosterone drug revenue in the United States in 2013 and a projection for 2018, in billion U.S. dollars. In 2013, testosterone drugs generated a revenue of 2.4 billion U.S. dollars.
Testosterone therapy

Testosterone therapy is often used to treat men with hypogonadism, where the body produces too little or no natural testosterone. Testosterone can be used as hormone replacement therapy and can be used to treat low libido in post-menopausal women. This form of therapy has also been reported to improve moods as well as energy. By 2018, annual revenue generated from testosterone drug sales in the United States is expected to reach 3.8 billion U.S. dollars. Testosterone use was among the highest in Canada and the United States as of 2011, with 385.5 monthly doses and 98.5 monthly doses per 1,000 population, respectively.

Transdermal application for testosterone for example, through application by skin patch, has become increasingly common. In Canada, Sweden, and the United States, transdermal testosterone application accounted for 97 percent, 78 percent, and 78 percent, respectively, as of 2011. Testosterone supplements can also be taken as a gel, mouth patch, and through injections or implants.

Individuals that enrolled in testosterone therapy prescription often had a prior prescription of hypertension or hyperlipidemia. As of 2014, 26.8 percent with hypertension and 26.5 percent diagnosed with hyperlipidemia enrolled in testosterone therapy prescription. Testosterone therapy has also been linked to adverse cardiovascular events. In individuals under or equal to 65 years of age, the myocardial infarction among men was at 5.27 per 1,000 per year prior to testosterone prescription. The post-prescription rate of myocardial infarction increased to 11.52 per 1,000 per year as of 2014.
Show more
Exclusive Premium statistic

Get a Premium Account for unrestrained access.
Benefits of our Premium membership:

  • Access to all Premium statistics
  • Download as XLS, PNG and PDF
  • Detailed source and background information
Premium Account
$49 per month*
(billed annually)
*Single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

View price details

Revenue in billion U.S. dollars
--
--
Revenue in billion U.S. dollars
--
--
Exclusive Premium statistic

Get a Premium Account for unrestrained access.
Benefits of our Premium membership:

  • Access to all Premium statistics
  • Download as XLS, PNG and PDF
  • Detailed source and background information
Premium Account
$49 per month*
(billed annually)
*Single license

Access to this and all other statistics on 80,000 topics from

$588 / Year

View price details

© Statista 2018

Download Settings Share
Chart type
Datalabels
Share on Social Media
Download started
Please be patient - this may take a moment
Description Source More information
This statistic depicts the annual testosterone drug revenue in the United States in 2013 and a projection for 2018, in billion U.S. dollars. In 2013, testosterone drugs generated a revenue of 2.4 billion U.S. dollars.
Testosterone therapy

Testosterone therapy is often used to treat men with hypogonadism, where the body produces too little or no natural testosterone. Testosterone can be used as hormone replacement therapy and can be used to treat low libido in post-menopausal women. This form of therapy has also been reported to improve moods as well as energy. By 2018, annual revenue generated from testosterone drug sales in the United States is expected to reach 3.8 billion U.S. dollars. Testosterone use was among the highest in Canada and the United States as of 2011, with 385.5 monthly doses and 98.5 monthly doses per 1,000 population, respectively.

Transdermal application for testosterone for example, through application by skin patch, has become increasingly common. In Canada, Sweden, and the United States, transdermal testosterone application accounted for 97 percent, 78 percent, and 78 percent, respectively, as of 2011. Testosterone supplements can also be taken as a gel, mouth patch, and through injections or implants.

Individuals that enrolled in testosterone therapy prescription often had a prior prescription of hypertension or hyperlipidemia. As of 2014, 26.8 percent with hypertension and 26.5 percent diagnosed with hyperlipidemia enrolled in testosterone therapy prescription. Testosterone therapy has also been linked to adverse cardiovascular events. In individuals under or equal to 65 years of age, the myocardial infarction among men was at 5.27 per 1,000 per year prior to testosterone prescription. The post-prescription rate of myocardial infarction increased to 11.52 per 1,000 per year as of 2014.
Show more
Release date
August 2014
Region
United States
Survey time period
2013 and 2014
Supplementary notes
* Projected.

Statista Accounts: Access All Statistics. Starting from $588 / Year

Statistics on "U.S. pharmaceutical industry"

  • Contribution to global pharma
The most important statistics
  • Overview
  • Companies
  • Research and development
The most important statistics
  • Generics
The most important statistics
  • Outlook
  • The consumer's view
The most important statistics

Statista for Your Company: The Research and Analysis Tool

  • Product Film
  • Statistics
  • Downloads

Our Premium Statistics - facts for your business

Currently, Statista provides more than 1 million statistics.
93 percent (all Premium content) are exclusively accessible via our professional accounts.

Unlimited access

As a Statista Premium customer, you receive unlimited access to all statistics at all times. Including downloads of data in the most common formats (XLS, PDF & PNG). Create relevant and significant statistics in no time.

You are in good company

Further Content: Statistics, Studies, and Topic Pages

Our Business Solutions: Save Time and Money

only

$588*

per year
Your advantages
  • Full access to all our statistics
  • Download as XLS, PDF & PNG
  • Relevant data: complete source information
All functions of our platform illustrated face-to-face
  • Learn how Statista supports your company
  • Extensive tour across the whole portal
  • Personal guidance by our support team
The knowledge database for your company
  • All functions of the Premium Account
  • Access to dossiers, forecasts and studies
  • Access to our international database
  • Publishing rights and other exclusive functions

Statistics on the topic

Topics

About Statista

Learn more about how Statista can support your business.

Request webinar